Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
4
×
life sciences
national blog main
clinical trials
fda
new york blog main
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
indiana blog main
indiana top stories
ipo
national
national top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
What
ipo
4
×
new
4
×
medicines
companies
million
therapeutics
activity
approvals
based
begin
bio
biogen
biosciences
biotech
biotechs
bio’s
black
brings
bubbles
cancer
cells
clamped
class
clinic
clinical
club
codiak
continued
covid
crop
delays
developing
diamond
drug
economic
eluded
exceeded
exosome
exosomes
fast
Language
unset
Current search:
cancer
×
ipo
×
new
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M